Author

B. Bowring

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Microbiology· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Research Focus:drug response / drug discovery· 1 Research Focus:host-pathogen & immune response· 1 Organism:human· 1 Assay:metagenomics· 1 Organism:mouse· 1 Assay:whole-genome sequencing· 1

Frequent Co-Authors

C. Venturini· 2 shared J. Iredell· 2 shared A. Fajardo-Lubian· 1 shared C. Devine· 1 shared E. Kettle· 1 shared N. Ben Zakour· 1 shared N. Thomson· 1 shared R. Cole· 1 shared

Activity by Year

2019-2020 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 33 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersMicrobiology

C. Venturini

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Differential effects of antibiotic treatment with piperacillin/tazobactam or ceftriaxone on the murine gut microbiota

C. Venturini, B. Bowring, A. Fajardo-Lubian, C. Devine, J. Iredell

This study compares the effects of piperacillin/tazobactam and ceftriaxone on the murine gut microbiota, finding that ceftriaxone causes more prolonged dysbiosis and reduced colonization resistance.

bioRxiv · May 28, 2020Microbiology

K. pneumoniae ST258 genomic variability and bacteriophage susceptibility

C. Venturini, N. Ben Zakour, B. Bowring, S. Morales, R. Cole, Z. Kovach, S. Branston, E. Kettle, N. Thomson, J. Iredell

The paper characterizes genomic variability in K. pneumoniae ST258 isolates and identifies phage susceptibility patterns, showing that effective phage therapy requires diverse phages targeting different capsule variants.

bioRxiv · May 5, 2019 · PreprintMicrobiology